Simmons Law Firm Adds Two Partners, Commitment to Helping Asbestos Victims Grows
EAST ALTON, Ill., Jan. 8 /PRNewswire/ -- The Simmons firm today announced the appointment of two new partners, Myles Epperson and Michael Stewart. Epperson and Stewart provide the proven experience required to help further the commitment of the Simmons firm's fight against asbestos-related diseases, including mesothelioma.
"Epperson and Stewart have been key players in fighting for the rights of individuals exposed to asbestos inside and outside the courtroom, helping hundreds of individuals and families injured by exposure to asbestos," said Chairman and CEO John Simmons. "They will provide great value as the Simmons firm continues to fight for victims of asbestos-related diseases and their families, as well as generate awareness, increase education, and help raise funds for research to find better care and hopefully a cure for mesothelioma."
Epperson joined the firm in 2002 as an attorney and works directly with patients and families affected by mesothelioma, a rare cancer caused by exposure to asbestos. He graduated cum laude from Southern Illinois University School of Law in Carbondale, Illinois in 1996.
Stewart, who joined Simmons in 2004 as an attorney, also focuses his practice on helping families affected by asbestos exposure. He was a member of the United States Marine Corps, where he received the Good Conduct Medal and was also honored with a Meritorious Mast Award on three separate occasions. He graduated from DePaul University College of Law in Chicago in 1995.
About Simmons Browder Gianaris Angelides & Barnerd LLC
The Simmons firm is a national law firm with nearly 50 attorneys, including 16 partners, and offices in Illinois and California. The firm has represented more than 2,000 patients and families affected by mesothelioma in nearly every state in the country. The firm also has pledged more than $10 million to cancer research and works with top mesothelioma medical experts throughout the country, supporting their work toward a cure. The firm also has practice areas in intellectual property, pharmaceutical litigation, and business litigation.
SOURCE Simmons Browder Gianaris Angelides & Barnerd LLC
Share this article